U.S. market Closed. Opens in 6 hours 37 minutes

RNA | Avidity Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue9.56M9.22M9.33M6.79M2.32M379.00K
Cost of Revenue2.10M1.39M639.00K37.60M14.54MN/A
Gross Profit7.46M7.84M8.69M-30.82M-12.22M379.00K
Operating Expenses243.06M188.14M127.38M51.06M19.65M10.88M
Selling, General & Admin52.09M37.73M26.20M13.46M5.11M2.44M
Research & Development190.97M150.40M101.18M37.60M14.54M8.44M
Other Operating Expenses-594.00K4.92M42.00K-78.00KN/AN/A
Operating Income-235.60M-178.91M-118.05M-44.28M-17.33M-10.50M
Other Expenses / Income23.38M4.92M42.00K-78.00K-7.40M-718.00K
Before Tax Income-212.22M-174.00M-118.01M-44.35M-24.73M-11.22M
Income Tax Expenses1.93M-4.92M-639.00K-373.00K7.39M718.00K
Net Income-212.22M-169.08M-117.37M-43.98M-32.12M-11.93M
Interest ExpensesN/A-5.69MN/A209.00K7.39M718.00K
Basic Shares Outstanding73.01M52.16M41.43M21.66M37.51M20.68M
Diluted Shares Outstanding73.01M52.16M41.43M21.66M37.51M20.68M
EBITDA-233.50M-178.91M-118.05M-44.28M-16.98M-10.12M
EBITDA Margin-2,442.44%-1,939.65%-1,265.83%-652.38%-732.38%-2,668.87%
EBIT-210.29M-179.69M-118.01M-44.15M-17.35M-10.50M
EBIT Margin-2,199.65%-1,948.02%-1,265.38%-650.45%-748.04%-2,769.92%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙